Biotech · Private company
Allievex Corporation
Track this companyFree. Adds Allievex Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AX 250Phase 2 · MPS III BClinicalTrials.gov · fetched Nov 12, 2026
- AX 250Phase 2 · Mucopolysaccharidosis Type IIIBClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Safety, Tolerability and Efficacy of ICV AX 250 Treatment in MPS IIIB -OLEPHASE4 · ENROLLING_BY_INVITATION · started Dec 2, 2022ClinicalTrials.gov NCT05492799 · fetched Nov 12, 2026
- A Treatment Extension Study of Mucopolysaccharidosis Type IIIBPHASE2 · UNKNOWN · started Feb 19, 2018ClinicalTrials.gov NCT03784287 · fetched Nov 12, 2026
- A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)UNKNOWN · started Nov 16, 2017ClinicalTrials.gov NCT03227042 · fetched Nov 12, 2026
- A Treatment Study of Mucopolysaccharidosis Type IIIBPHASE1_PHASE2 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02754076 · fetched Nov 12, 2026
- A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02493998 · fetched Nov 12, 2026